Clinical Trial Update: First in Human Study of TORL-3-600 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of TORL-3-600 in participants with advanced cancer, including colorectal cancer; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TORL-3-600

Snippet

Sponsor: TORL Biotherapeutics, LLC | Conditions: Advanced Solid Tumor, Colorectal Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING